title: Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate.
abstract: Transient paraparesis has been reported with intrathecal chemotherapy agents and the most common cause is an incomplete inflammatory myelopathy. We report a case of a 30-year-old man diagnosed with acute lymphoblastic leukaemia who developed subacute anterior lumbosacral polyradiculopathy following intrathecal methotrexate, an unusual complication of intrathecal chemotherapy in adults. Spinal magnetic resonance discarded myelopathy. Cerebrospinal fluid exam showed elevation of protein, mononuclear pleocytosis and immunoglobulin synthesis. Electrodiagnostic study showed alterations of sensory and motor conductions only in lower limbs, consistent with multilevel radiculopathy. Differential diagnosis included toxic and neoplastic polyradiculopathy, and axonal variant of acute inflammatory demyelinating polyradiculoneuropathy. The authors review possible pathogenic mechanisms and propose several therapeutic and preventive options.
authors.affiliation: Department of Neurology, Hospital Universitario La Fe, at Valencia, Spain. med004201@saludalia.com
authors.forename: Ana M
authors.initials: AM
authors.lastname: Pascual
authors.forename: Francisco
authors.initials: F
authors.lastname: Coret
authors.forename: Bonaventura
authors.initials: B
authors.lastname: Casanova
authors.forename: Miguel J A
authors.initials: MJ
authors.lastname: Láinez
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004347:Drug Interactions / Q000502:physiology; D017809:Fatal Outcome; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007278:Injections, Spinal / Q000009:adverse effects; D007866:Leg / Q000294:innervation / Q000503:physiopathology; D008160:Lumbosacral Plexus / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009046:Motor Neurons / Q000473:pathology; D018482:Muscle, Skeletal / Q000294:innervation / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology; D010243:Paralysis / Q000139:chemically induced; D020335:Paraparesis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D011128:Polyradiculopathy / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics; D012141:Respiratory Tract Infections; D018805:Sepsis; D013126:Spinal Nerve Roots / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D001750:Urinary Bladder, Neurogenic / Q000139:chemically induced
chemical_list: D000964:Antimetabolites, Antineoplastic; D006854:Hydrocortisone; D008727:Methotrexate